DEUTSCHE BANK AG\ - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 118 filers reported holding PARATEK PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.95 and the average weighting 0.1%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$83,000
-41.1%
28,110
-10.1%
0.00%
Q4 2021$141,000
-2.8%
31,268
+5.1%
0.00%
Q3 2021$145,000
-90.5%
29,762
-86.7%
0.00%
-100.0%
Q2 2021$1,531,000
-9.9%
224,587
-6.7%
0.00%0.0%
Q1 2021$1,699,000
+50.9%
240,597
+33.7%
0.00%0.0%
Q4 2020$1,126,000
-12.9%
179,964
-24.7%
0.00%0.0%
Q3 2020$1,293,000
+146.8%
239,011
+138.2%
0.00%
Q2 2020$524,000
+1355.6%
100,333
+784.1%
0.00%
Q1 2020$36,000
-23.4%
11,348
-5.6%
0.00%
Q4 2019$47,000
+23.7%
12,018
+32.7%
0.00%
Q3 2019$38,000
-90.0%
9,058
-90.6%
0.00%
Q2 2019$381,000
-77.3%
96,253
-69.4%
0.00%
-100.0%
Q1 2019$1,682,000
+3.6%
314,136
-0.8%
0.00%0.0%
Q4 2018$1,624,000
-69.8%
316,661
-42.9%
0.00%
-50.0%
Q3 2018$5,379,000
-53.9%
554,609
-51.5%
0.00%
-33.3%
Q2 2018$11,659,000
+79.7%
1,143,139
+129.1%
0.00%0.0%
Q1 2018$6,487,000
-3.7%
499,051
+32.6%
0.00%
-25.0%
Q4 2017$6,734,000
-32.3%
376,285
-5.0%
0.00%
-42.9%
Q3 2017$9,943,000
-2.3%
396,274
-6.2%
0.01%0.0%
Q2 2017$10,175,000
+120.1%
422,273
+75.7%
0.01%
+133.3%
Q1 2017$4,623,000
+136.5%
240,286
+89.0%
0.00%
+50.0%
Q4 2016$1,955,000
+13.5%
127,122
-4.1%
0.00%
+100.0%
Q3 2016$1,723,000
+30.2%
132,571
+39.3%
0.00%0.0%
Q2 2016$1,323,000
+208.4%
95,180
+235.9%
0.00%
Q1 2016$429,000
-21.0%
28,340
-1.4%
0.00%
Q4 2015$543,000
-42.9%
28,748
-42.7%
0.00%
-100.0%
Q3 2015$951,000
-43.5%
50,171
-23.3%
0.00%0.0%
Q2 2015$1,684,000
+33.1%
65,414
+61.6%
0.00%0.0%
Q1 2015$1,265,000
-14.1%
40,484
+6.0%
0.00%0.0%
Q4 2014$1,472,00038,2000.00%
Other shareholders

There were no reported owners of PARATEK PHARMACEUTICALS INC in Q2 2021.

NameSharesValueWeighting ↓
View complete list of PARATEK PHARMACEUTICALS INC shareholders